EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Delayed diagnostic imaging but stable treatment initiation for kidney cancer during the COVID-19 pandemic: a Hungarian cohort study

László Rumi, Árpád Szántó, Dániel Bányai, Éva Szabó, Szabolcs Bellyei, Dóra Hubai, Balázs Takáts, Tamás Bodnár, János Girán, István Kiss, Árpád Boronkai, Éva Pozsgai

Pathology & Oncology Research · 13.05.2026 · 32

DOI: 10.3389/pore.2026.1612411 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pathology & Oncology Research, online erschienen am 13.05.2026. Verfasst von László Rumi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Urology Clinic, University of Pécs Clinical Center, Pécs, Hungary. Hauptthemen laut MEDLINE: COVID-19, Kidney Neoplasms, Time-to-Treatment, Carcinoma, Renal Cell. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives The COVID-19 pandemic influenced cancer care worldwide, delaying diagnosis and treatment. We compared waiting times — time to initial diagnostic imaging, time to treatment, time to histopathological diagnosis, and length of hospital stay — of kidney cancer patients between pre-COVID-19 and COVID-19 periods at a large regional Hungarian clinical center. We also aimed to identify factors predicting prolonged waiting times.

Methods

Data from 400 adult kidney cancer patients (all histologically renal cell carcinoma) at the University of Pécs Urology Clinic were analyzed retrospectively, for two periods (1 January 2019–15 March 2020, pre-pandemic; 16 March 2020–13 May 2021, pandemic). Demographic and clinical characteristics were collected, and time intervals calculated from electronic health records, followed by statistical analyses.

Results

Median time from symptom onset to initial diagnostic imaging increased significantly from 7.5 to 34 days during the pandemic (p = 0.026), while time to treatment (p = 0.492), time to histopathological diagnosis (p = 0.575), and length of hospital stay (p = 0.319) remained stable. Median healthcare-related waiting times (time to treatment and time to histopathological diagnosis) were comparatively long (range: 95.5–111 days). Advanced-stage disease (III–IV) was protective for prolonged time to initial diagnostic imaging (OR 0.205, 95% CI 0.074–0.568) pre-pandemic and for prolonged time to histopathological diagnosis (OR 0.496, 95% CI 0.254–0.971) during the pandemic. No other demographic or clinical factors influenced waiting times significantly.

Conclusion

The pandemic prolonged the interval from symptom onset to initial diagnostic testing, likely due to fear-driven healthcare avoidance by patients, but did not affect healthcare-related waiting times. Advanced-stage disease predicted shorter waiting times, with variable influence across periods. Our findings highlight the need for patient education and careful prioritization of care, with waiting times exceeding those reported in other international settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Kidney NeoplasmsTime-to-TreatmentCarcinoma, Renal CellHumansMaleFemaleHungaryMiddle AgedRetrospective StudiesAgedTreatment DelaySARS-CoV-2AdultDelayed DiagnosisPandemicsWaiting ListsAged, 80 and over

Stichwörter der Autor:innen

COVID-19advanced-stagekidney cancerpredictive factorrenal cell carcinomatime to diagnosistime to treatmentwaiting time

Autor:innen und Institutionen

  • Urology Clinic, University of Pécs Clinical Center, Pécs, Hungary.
  • Department of Otorhinolaryngology, University of Pécs Clinical Center, Pécs, Hungary.
  • Department of Oncotherapy, University of Pécs Clinical Center, Pécs, Hungary.
  • Klinik für Anästhesie, Luzerner Kantonsspital, Sursee, Switzerland.
  • Department of Public Health Medicine, University of Pécs Medical School, Pécs, Hungary.
  • Clinical and Health Data Analytics Lab, Department of Public Health Medicine, University of Pécs Medical School, Pécs, Hungary.

Zitieren

APA

Rumi, L., Szántó, Á., Bányai, D., Szabó, É., Bellyei, S., Hubai, D., Takáts, B., Bodnár, T., Girán, J., Kiss, I., Boronkai, Á., & Pozsgai, É. (2026). Delayed diagnostic imaging but stable treatment initiation for kidney cancer during the COVID-19 pandemic: a Hungarian cohort study. Pathology & Oncology Research, 32. https://doi.org/10.3389/pore.2026.1612411

Vancouver

Rumi L, Szántó Á, Bányai D, Szabó É, Bellyei S, Hubai D, et al. Delayed diagnostic imaging but stable treatment initiation for kidney cancer during the COVID-19 pandemic: a Hungarian cohort study. Pathology & Oncology Research. 2026;32. doi:10.3389/pore.2026.1612411

BibTeX
@article{Rumi2026,
  author = {Rumi, László and Szántó, Árpád and Bányai, Dániel and Szabó, Éva and Bellyei, Szabolcs and Hubai, Dóra and Takáts, Balázs and Bodnár, Tamás and Girán, János and Kiss, István and Boronkai, Árpád and Pozsgai, Éva},
  title = {Delayed diagnostic imaging but stable treatment initiation for kidney cancer during the COVID-19 pandemic: a Hungarian cohort study},
  journal = {Pathology & Oncology Research},
  year = {2026},
  volume = {32},
  doi = {10.3389/pore.2026.1612411}
}
Kostenlos starten →